There is someone buying up lots of shares, or a consortium of funds, the steady increase in share price for several days at about a rate of $1 a day, there may be excellent positive events in the coming weeks.
Can someone explain why it keeps going higher ?
Does anyone think that with the new processors, and technology at Xilinx, they will be key on penetrating more of the markets and growing significantly over the next 3 years ? Currently the market cap is tiny compared to Intel. The stock may require a 4 to 1 split soon.
XLNX is in a great position with the customers, and technology and value added innovative semi's. Hence I would suspect a continuation of the appreciation of the share prices modestly.
Its a casino game and its fun is it not. But seriously, all it would take is a Bloomberg headline or something regarding aluminum demand and down go the share prices.
Things can quickly get ugly and messy on a dime, the economy is deflationary globally, and China is getting softer and softer. The US dollar is rising globally a lot recently, and this will diminish competitiveness of China, and USA as China pegs their fake economy currency like UK did in the late 1800's.
Look at vehicle sales volumes, and other industries that use aluminium, and look at prices of the metal for an indication.
One man's very LATE idea of where the share price will trade in weeks from now is a JOKE.
I say get out soon while the market tanks in the coming weeks.
Get in again in the summer if the stock price is below $10.
Yes, I failed to mention, you are correct, for game changers, there is almost ALWAYS a committee meeting, that happened by Tysabri for ELAN Pharma a few years ago with their novel treatment, the drug was approved and the share went over $20 after trading as low as $2 on near bankruptcy.
The committee meeting typically means, that there will maybe be some sort of label statement modification or warning, or that further post vigilance studies be conducted after approved, or the product will be recommended as a secondary to injections.
Typically it means there will be approval in my opinion, just with a dilution of the marketing impact int he short run, however this has happened in the past.
They will probably take into account patients opinions, and independent MD advice.
The may mitigate the revenue only in the early stages of sales, but should clear up after a few quarters of sales and further safety data.
This is just my guess, i could easily be wrong ! but its worth holding for sure, and i would suspect the shares will still rise above $20 after approval and eventually grow over time.
Totally under rated share price.